P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Tag: Acadia

DayBue Announcement

Acadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is Now Available for the Treatment of Rett Syndrome  — Commercial launch of DAYBUE offers Rett syndrome community the first and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000… Read More